Gene · 5889
Papers3,668
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,668
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterization of exceptional responders with long-term PARP inhibitor therapy in recurrent ovarian cancer: an analysis of 23 patients from Charité. | Arch Gynecol Obstet | 2026 | 41746394 | PubTator, text mining | PubMed |
| CDX2 Expression and Fluoropyrimidine Response in Rare Non-GI Tumors: A Three-Case Series. | Curr Oncol | 2026 | 41744890 | PubTator, text mining | PubMed |
| Possible link between the apparently pathogenic FANCI variant and beneficial effects in sports performance. | Front Genet | 2026 | 41732159 | PubTator, text mining | PubMed |
| Role of laser therapy in enhancing chemotherapy efficiency in breast cancer: low level laser therapy, photochemotherapy, and photodynamic therapy as promising treatments. | Lasers Med Sci | 2026 | 41731105 | PubTator, text mining | PubMed |
| Impact of immune-related adverse events on response to neoadjuvant chemoimmunotherapy in triple-negative breast cancer: a single-institution retrospective study. | Breast Cancer Res Treat | 2026 | 41729316 | PubTator, text mining | PubMed |
| Case Report: A rare case of serous cystadenocarcinoma of the ovary with a benign teratoma in the other ovary. | Front Med (Lausanne) | 2026 | 41728606 | PubTator, text mining | PubMed |
| Epidemiological Profile, Clinical Characteristics, and Management of Ovarian Cancer in Eastern India: A Hospital-Based Study. | Cureus | 2026 | 41728398 | PubTator, text mining | PubMed |
| Quantifying rate-limiting genetic variation in breast and ovarian tumourigenesis. | EBioMedicine | 2026 | 41724111 | PubTator, text mining | PubMed |
| RAD51C-XRCC3 complex regulates FANCM-mediated R-loop resolution to safeguard genome integrity. | Sci Adv | 2026 | 41719405 | PubTator, text mining | PubMed |
| Microbe-associated molecular patterns differentially mediate carcinogenic alterations of the breast tissue in the context of obesity. | Neoplasia | 2026 | 41707315 | PubTator, text mining | PubMed |
| Cosegregation analysis following an excellent response to olaparib in a pancreatic cancer patient carrier of BRCA2:c.7892 T > C variant enables its reclassification from VUS to pathogenic. | BJC Rep | 2026 | 41699384 | PubTator, text mining | PubMed |
| Homologous recombination deficiency in primary ER-positive and HER2-negative breast cancer. | Commun Med (Lond) | 2026 | 41699108 | PubTator, text mining | PubMed |
| Uptake of cascade tests in relatives of patients undergoing cancer precision medicine in Japan. | Jpn J Clin Oncol | 2026 | 41691475 | PubTator, text mining | PubMed |
| Discovering Hereditary Risk Through Surveillance: A Prospective Genetic Analysis of Individuals With Familial Pancreatic Cancer. | United European Gastroenterol J | 2026 | 41691430 | PubTator, text mining | PubMed |
| Evaluation of homologous recombination testing in ovarian carcinoma. | Virchows Arch | 2026 | 41652233 | PubTator, text mining | PubMed |
| Breast Cancer Brain Metastases: Current Understanding and Future Directions. | Curr Oncol Rep | 2026 | 41642399 | PubTator, text mining | PubMed |
| Hereditary ovarian cancer in women with African ancestry: a scoping review. | Fam Cancer | 2026 | 41619087 | PubTator, text mining | PubMed |
| Results of a multigene panel testing approach targeting patients with suspected genetic predisposition to pancreatic ductal adenocarcinoma. | Eur J Hum Genet | 2026 | 41611968 | PubTator, text mining | PubMed |
| Impact of Hereditary Cancer Susceptibility in Solid-Organ Transplant Recipients. | JCO Precis Oncol | 2026 | 41576304 | PubTator, text mining | PubMed |
| Assessing the Detection Power of Genome-Wide Copy Number Variation Profiles in Prostate Cancer Using Simulated Shallow Whole-Genome Sequencing Data. | JCO Clin Cancer Inform | 2026 | 41576301 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5889/papers?page=4